Indiana General Assembly passes landmark 340B anti-discrimination bill (HB 1405)

On April 22, 2021, the Indiana General Assembly passed a bill (HB 1405) that protects Indiana 340B safety-net providers from discriminatory and predatory practices by pharmacy benefit managers (PBMs).  HB 1405 is expected to be signed into law by the governor of Indiana, Eric J. Holcomb, next week and without objection.  HB 1405 prohibits a contract between…

United Therapeutics Announces Details on Phase Two of its Restrict Contract Pharmacy Policy

By letter dated April 12, drug manufacturer United Therapeutics (UT) announced additional details regarding the second phase of its restrictive contract pharmacy policy.  UT initially sent letters to covered entities in November 2020 notifying them that UT would be implementing a new contract pharmacy policy in two phases.  Under the first phase, UT stated that it will deny all…

Gilead Delays Harmful Changes to Patient Assistance Program Until January 1, 2022

Last week, Gilead issued a statement that it is delaying a change to its Advancing Access® Patient Assistance/Medication Assistance Program (PAP/MAP) until January 1, 2022. Gilead previously announced that, effective Oct. 1, 2021, pharmacies dispensing drugs to clients enrolled in the PAP/MAP would only be reimbursed for “the amount paid for each bottle plus a dispensing fee and an administrative…

New Research Shows 340B Hospitals Provide More Medication Access Services Than Non-340B Hospitals

Below is a press release issued by CV340B highlighting new research showing that 340B hospitals provide more medication access services than non-340B hospitals.  The research was performed by the University of Illinois Chicago and funded, in part, by CV340B. *** CV340B PRESS STATEMENT ON MEDICATION ASSISTANCE PROGRAM STUDY (D0942315)CV340B PRESS STATEMENT ON MEDICATION ASSISTANCE PROGRAM…